AAPL   382.67 (+0.34%)
MSFT   213.82 (+0.47%)
FB   242.69 (-0.37%)
AMZN   3,144.01 (+2.04%)
NVDA   419.14 (+2.57%)
BABA   260.50 (+1.09%)
T   29.67 (-2.59%)
DIS   116.45 (-0.18%)
BAC   22.57 (-2.29%)
BA   174.44 (-3.13%)
AAPL   382.67 (+0.34%)
MSFT   213.82 (+0.47%)
FB   242.69 (-0.37%)
AMZN   3,144.01 (+2.04%)
NVDA   419.14 (+2.57%)
BABA   260.50 (+1.09%)
T   29.67 (-2.59%)
DIS   116.45 (-0.18%)
BAC   22.57 (-2.29%)
BA   174.44 (-3.13%)
AAPL   382.67 (+0.34%)
MSFT   213.82 (+0.47%)
FB   242.69 (-0.37%)
AMZN   3,144.01 (+2.04%)
NVDA   419.14 (+2.57%)
BABA   260.50 (+1.09%)
T   29.67 (-2.59%)
DIS   116.45 (-0.18%)
BAC   22.57 (-2.29%)
BA   174.44 (-3.13%)
AAPL   382.67 (+0.34%)
MSFT   213.82 (+0.47%)
FB   242.69 (-0.37%)
AMZN   3,144.01 (+2.04%)
NVDA   419.14 (+2.57%)
BABA   260.50 (+1.09%)
T   29.67 (-2.59%)
DIS   116.45 (-0.18%)
BAC   22.57 (-2.29%)
BA   174.44 (-3.13%)
Log in

NYSE:TMOThermo Fisher Scientific Stock Price, Forecast & News

$386.70
+0.07 (+0.02 %)
(As of 07/9/2020 02:22 PM ET)
Add
Compare
Today's Range
$383.55
Now: $386.70
$391.38
50-Day Range
$332.57
MA: $350.07
$382.27
52-Week Range
$250.21
Now: $386.70
$395.00
Volume35,590 shs
Average Volume1.43 million shs
Market Capitalization$152.73 billion
P/E Ratio42.40
Dividend Yield0.23%
Beta1.04
Thermo Fisher Scientific Inc. provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide. Its Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of new drugs and vaccines, and diagnosis of diseases to pharmaceutical, biotechnology, agricultural, clinical, academic, and government markets. Its Analytical Instruments segment offers instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and research and industrial markets, as well as clinical laboratories. Its Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; blood-test systems and antibody tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; products for cancer diagnosis and medical research in histology, cytology, and hematology; human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel products. It serves healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. Its Laboratory Products and Services segment offers laboratory refrigerators and freezers, and ultralow-temperature freezers and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis and laboratory equipment; laboratory plastics; laboratory chemicals; research and safety market channel; and pharma services. The company was founded in 1956 and is headquartered in Waltham, Massachusetts.
Read More
Thermo Fisher Scientific logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.4Community Rank: 3.6Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.86 out of 5 stars


Industry, Sector and Symbol

Industry Measuring & controlling devices, not elsewhere classified
Sub-IndustryLife Sciences Tools & Services
SectorMedical
CUSIP88355610
Phone781-622-1000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$25.54 billion
Cash Flow$18.40 per share
Book Value$74.00 per share

Profitability

Net Income$3.70 billion

Miscellaneous

Employees75,000
Market Cap$152.73 billion
Next Earnings Date7/22/2020 (Confirmed)
OptionableOptionable

Receive TMO News and Ratings via Email

Sign-up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter.

Thermo Fisher Scientific (NYSE:TMO) Frequently Asked Questions

How has Thermo Fisher Scientific's stock been impacted by COVID-19 (Coronavirus)?

Thermo Fisher Scientific's stock was trading at $289.38 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, TMO shares have increased by 33.5% and is now trading at $386.4150. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Thermo Fisher Scientific?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Thermo Fisher Scientific in the last year. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Thermo Fisher Scientific.

When is Thermo Fisher Scientific's next earnings date?

Thermo Fisher Scientific is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Thermo Fisher Scientific.

How can I listen to Thermo Fisher Scientific's earnings call?

Thermo Fisher Scientific will be holding an earnings conference call on Wednesday, July 22nd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Thermo Fisher Scientific's earnings last quarter?

Thermo Fisher Scientific Inc. (NYSE:TMO) issued its quarterly earnings results on Wednesday, April, 22nd. The medical research company reported $2.94 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $2.79 by $0.15. The medical research company had revenue of $6.23 billion for the quarter, compared to analyst estimates of $6.18 billion. Thermo Fisher Scientific had a net margin of 14.31% and a return on equity of 17.25%. The company's revenue for the quarter was up 1.7% on a year-over-year basis. During the same period in the previous year, the business posted $2.81 EPS. View Thermo Fisher Scientific's earnings history.

How often does Thermo Fisher Scientific pay dividends? What is the dividend yield for Thermo Fisher Scientific?

Thermo Fisher Scientific declared a quarterly dividend on Wednesday, May 20th. Shareholders of record on Monday, June 15th will be paid a dividend of $0.22 per share on Wednesday, July 15th. This represents a $0.88 dividend on an annualized basis and a dividend yield of 0.23%. The ex-dividend date of this dividend is Friday, June 12th. View Thermo Fisher Scientific's dividend history.

How will Thermo Fisher Scientific's stock buyback program work?

Thermo Fisher Scientific announced that its Board of Directors has initiated a share buyback program on Friday, November 8th 2019, which authorizes the company to repurchase $2,500,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to reacquire shares of its stock through open market purchases. Stock repurchase programs are generally an indication that the company's management believes its stock is undervalued.

What guidance has Thermo Fisher Scientific issued on next quarter's earnings?

Thermo Fisher Scientific issued an update on its second quarter 2020 Pre-Market earnings guidance on Monday, July, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $6.948-6.948 billion, compared to the consensus revenue estimate of $5.82 billion.

What price target have analysts set for TMO?

13 brokers have issued 12 month target prices for Thermo Fisher Scientific's stock. Their forecasts range from $315.00 to $415.00. On average, they anticipate Thermo Fisher Scientific's share price to reach $357.42 in the next twelve months. This suggests that the stock has a possible downside of 7.5%. View analysts' price targets for Thermo Fisher Scientific.

Has Thermo Fisher Scientific been receiving favorable news coverage?

Media headlines about TMO stock have been trending negative on Thursday, InfoTrie Sentiment Analysis reports. The research group rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Thermo Fisher Scientific earned a media sentiment score of -2.1 on InfoTrie's scale. They also assigned news headlines about the medical research company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Thermo Fisher Scientific.

Are investors shorting Thermo Fisher Scientific?

Thermo Fisher Scientific saw a increase in short interest in June. As of June 30th, there was short interest totaling 3,660,000 shares, an increase of 6.1% from the June 15th total of 3,450,000 shares. Based on an average daily trading volume, of 1,740,000 shares, the short-interest ratio is currently 2.1 days. Approximately 0.9% of the company's shares are short sold. View Thermo Fisher Scientific's Current Options Chain.

Who are some of Thermo Fisher Scientific's key competitors?

What other stocks do shareholders of Thermo Fisher Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Thermo Fisher Scientific investors own include Home Depot (HD), Alibaba Group (BABA), Walt Disney (DIS), Johnson & Johnson (JNJ), Cisco Systems (CSCO), CVS Health (CVS), Honeywell International (HON), NVIDIA (NVDA), Visa (V) and Procter & Gamble (PG).

Who are Thermo Fisher Scientific's key executives?

Thermo Fisher Scientific's management team includes the following people:
  • Mr. Marc N. Casper, CEO, Pres & Director (Age 51)
  • Mr. Stephen Williamson, Sr. VP & CFO (Age 52)
  • Mr. Mark P. Stevenson, Exec. VP & COO (Age 56)
  • Mr. Gregory J. Herrema, Sr. VP & Pres of Customer Channels (Age 53)
  • Mr. Patrick M. Durbin, Sr. VP & Pres of Specialty Diagnostics (Age 52)

What is Thermo Fisher Scientific's stock symbol?

Thermo Fisher Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "TMO."

Who are Thermo Fisher Scientific's major shareholders?

Thermo Fisher Scientific's stock is owned by a variety of retail and institutional investors. Top institutional investors include Envestnet Asset Management Inc. (0.12%), Robecosam AG (0.08%), Confluence Investment Management LLC (0.03%), DNB Asset Management AS (0.03%), State of Alaska Department of Revenue (0.02%) and Chesley Taft & Associates LLC (0.01%). Company insiders that own Thermo Fisher Scientific stock include C Martin Harris, Gregory J Herrema, Jim P Manzi, Marc N Casper, Mark Stevenson, Patrick M Durbin, Peter E Hornstra, Stephen Williamson and Tyler Jacks. View institutional ownership trends for Thermo Fisher Scientific.

Which institutional investors are selling Thermo Fisher Scientific stock?

TMO stock was sold by a variety of institutional investors in the last quarter, including Robecosam AG, State of Alaska Department of Revenue, Renaissance Investment Group LLC, Confluence Investment Management LLC, Chesley Taft & Associates LLC, Bright Rock Capital Management LLC, Rockland Trust Co., and Mount Yale Investment Advisors LLC. Company insiders that have sold Thermo Fisher Scientific company stock in the last year include Jim P Manzi, Marc N Casper, Mark Stevenson, and Stephen Williamson. View insider buying and selling activity for Thermo Fisher Scientific.

Which institutional investors are buying Thermo Fisher Scientific stock?

TMO stock was purchased by a variety of institutional investors in the last quarter, including Envestnet Asset Management Inc., HNP Capital LLC, DNB Asset Management AS, Municipal Employees Retirement System of Michigan, Platte River Wealth Advisors LLC, Patton Fund Management Inc., West Branch Capital LLC, and Carnegie Capital Asset Management LLC. View insider buying and selling activity for Thermo Fisher Scientific.

How do I buy shares of Thermo Fisher Scientific?

Shares of TMO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Thermo Fisher Scientific's stock price today?

One share of TMO stock can currently be purchased for approximately $386.42.

How big of a company is Thermo Fisher Scientific?

Thermo Fisher Scientific has a market capitalization of $152.61 billion and generates $25.54 billion in revenue each year. The medical research company earns $3.70 billion in net income (profit) each year or $12.35 on an earnings per share basis. Thermo Fisher Scientific employs 75,000 workers across the globe.

What is Thermo Fisher Scientific's official website?

The official website for Thermo Fisher Scientific is www.thermofisher.com.

How can I contact Thermo Fisher Scientific?

Thermo Fisher Scientific's mailing address is 168 Third Avenue, Waltham MA, 02451. The medical research company can be reached via phone at 781-622-1000 or via email at [email protected]

This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.